Discounted MRP:377.40 444.0015% Off
*inclusive of all taxes
Dapagliflozin This SGLT-2(Sodium-Glucose Co-Transporter-2) inhibitor has been recently tested in type 2 DM patients. After a single daily dose, it produces round-the-clock glucosuria and lowers blood glucose levels. Metformin is now established as a first-choice drug for all type 2 DM (Diabetes Mellitus) patients.